WO1998058628A1 - Cosmetic composition containing a whitening agent and an exfoliant - Google Patents
Cosmetic composition containing a whitening agent and an exfoliant Download PDFInfo
- Publication number
- WO1998058628A1 WO1998058628A1 PCT/US1998/012453 US9812453W WO9858628A1 WO 1998058628 A1 WO1998058628 A1 WO 1998058628A1 US 9812453 W US9812453 W US 9812453W WO 9858628 A1 WO9858628 A1 WO 9858628A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cosmetic
- acid
- skin
- derivatives
- cosmetic composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/90—Block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- the present invention relates to cosmetic compositions including delivery systems that provide new ways of delivering dermatologically active agents to cosmetically significant areas of the stratum corneum.
- Compositions of the invention are particularly, but not exclusively, useful as skin lightening compositions.
- the invention also includes a stabilized anhydrous delivery system for water soluble acids.
- the present invention relates to a method of improving skin tone, moisturization and skin firmness.
- compositions have been used to reduce skin pigmentation and improve skin tone. These compositions include kojic acid and its derivatives.
- alpha hydroxy carboxylic acids of relatively/low molecular weight, for example with 10 carbon or less.
- alpha hydroxy acids these acids are known to have a number of useful effects on the skin.
- alpha hydroxy acids can moisturize dry skin and improve various disorders including acne, psoriasis and other skin anomalies.
- AHA's are also effective in revitalizing the skin. Depending upon the concentration and length of application they can cause, or stimulate, exfoliation which is the removal of outer keratinous or horny tissue layers, and stimulate renewal of new skin layers to provide a significant improvement in the appearance of the skin.
- Some AHA's that have been used to provide these benefits are the simplest alpha hydroxy acid, namely lactic acid, as well as glycolic acid, citric acid and malic acid. These acids are also known as “fruit acids” because they are found in fruits and in the case of glycolic acid, in sugar cane. There are many other AHA's, or equivalent alpha keto acids and the like, that are known, or have been suggested for use in revitalizing skin or otherwise providing useful dermatological skin functions. Some beta hydroxy acids, for example salicylic acid, also have useful dermatological properties. Some such "skin acids” are disclosed in Yu et al., U.S. Patent No. 5,091 ,171 the disclosure of which is hereby incorporated herein by reference thereto.
- the AHA's of interest are usually quite hydrophilic, dissolve readily in water and, in the case of lactic acid become liquid around room temperature (about 16.8°C). Such hydrophilicity is usually incompatible with common hydrophobic cosmetics.
- the anhydrous nature of such cosmetics means that small quantities of active hydrophilic agents, for example, AHA's may either lose their activity due to chemical or physico-chemical combination, or fail to be delivered to the skin surface in an adequately hydrophilic or aqueous environment to be effective.
- preferred environments for such agents are significantly acidic, a condition which is difficult to provide at skin surfaces treated with anhydrous, or substantially hydrophobic, cosmetics. Avoiding irritation is of special significance to products intended for daily use.
- a topically applied cosmetic composition comprising: a) a whitening agent selected from the group consisting of kojic acid and derivatives thereof; ascorbic acid and derivatives thereof, including magnesium ascorbic acid; hydroquinone; bearberry extract; licorice extract; mulberry extract; arbutin; and mixtures thereof; b) an exfoliant selected from the group consisting of lactic acid, glycolic acid, malic acid, citric acid and salicylic acid; c) a sufficient quantity of an adsorbent or absorbent particulate carrier to support the exfoliant; and d) a cosmetic base, the base having a sufficient quantity of a film-forming agent to produce a desired cosmetic film when the cosmetic composition is applied to the skin.
- a stabilized whitening composition comprising a whitener selected from kojic acid and derivatives thereof; ascorbic acid and derivatives thereof, including magnesium ascorbic acid; hydroquinone; bearberry extract; licorice extract; mulberry extract; arbutin; and mixtures thereof; and a gellant selected from castor oil derivatives, silicone polymers, silicone gums, bentonite clays, and styrene/ethylene/propylene block copolymers.
- a method of lightening skin comprising: applying to the surface of skin a source of water followed by applying to the skin a whitening cosmetic composition including: a) a whitening agent selected from the group consisting of kojic acid and derivatives thereof; ascorbic acid and derivatives thereof, including magnesium ascorbic acid; hydroquinone; bearberry extract; licorice extract; mulberry extract; arbutin; and mixtures thereof; b) an exfoliant selected from the group consisting of lactic acid, glycolic acid, malic acid, citric acid and salicylic acid; c) a sufficient quantity of an adsorbent or absorbent particulate carrier to support the exfoliant; and d) a cosmetic base, the base having a sufficient quantity of a film-forming agent to produce a desired cosmetic film when the cosmetic composition is applied to the skin.
- a whitening cosmetic composition including: a) a whitening agent selected from the group consisting of kojic acid and derivatives thereof; ascorbic acid and derivatives thereof, including magnesium
- a topically applied hydrophobic, essentially anhydrous cosmetic composition comprising: a) a whitening agent selected from the group consisting of kojic acid, ascorbic acid, and mixtures thereof; b) an exfoliant of lactic acid; c) an anti-aging agent selected from Vitamin A Palmitate and retinol and its derivatives; d) a sufficient quantity of an adsorbent or absorbent particulate carrier to support the exfoliant; and e) a cosmetic base, the base having a sufficient quantity of a film-forming agent to produce a desired cosmetic film when the cosmetic composition is applied to the skin.
- Preferred embodiments of the invention relate to novel cosmetic compositions containing a stabilized whitening composition, an exfoliant and an anti-aging agent to improve skin whitening.
- Whitening agents can include but are not limited to kojic acid and derivatives thereof; ascorbic acid and derivatives thereof, including magnesium ascorbic acid; hydroquinone; bearberry extract; licorice extract; mulberry extract; arbutin; and mixtures thereof.
- Other whitening agents will be apparent to the cosmetic formulator.
- the preferred whitening agents for use in the present invention are kojic acid and its derivatives and ascorbic acid and its derivatives.
- the whitening agent of the present invention is preferably stabilized with an anhydrous gellant.
- anhydrous gellants of the present invention include, but are not limited to castor oil derivatives, for example, trihydroxystearine; silicone polymers, silicone gums, bentonite clays; and styrene/ethylene/propylene block copolymers. If the gellant contains metallic ions, it should first be treated with an appropriate chelating agent to prevent reaction between the metallic ions and the active ingredients. Appropriate chelating agents are well understood by the artisan skilled in cosmetic formulation.
- the use of the gellant allows the water soluble acids to be stabilized for inclusion in an anhydrous delivery system of the present invention.
- the whitening agent of the present invention is preferably present in the cosmetic composition of the present invention in an amount of about 0.10 to about 10.0 % by weight, more preferably about 0.50 to about 5.0 % by weight and most preferably about 1.0 to about 3.0 % by weight.
- the whitening agent can be combined with the gellant before combination with the cosmetic base or the whitening agent and the gellant may be incorporated sequentially into the cosmetic base.
- An exfoliant is also used in the composition according to the present invention.
- the exfoliant not only improves the whitening/lightening properties of the whitening agent but also improves the overall look and feel of the skin.
- An exfoliant such as, an alpha hydroxy acid, namely lactic acid, as well as, glycolic acid, citric acid and malice acid can be used in the cosmetic composition of the present invention.
- AHA's, or equivalent alpha keto acids and the like that are known, including some beta hydroxy acids, for example salicylic acid, that may also be used in accordance with the present invention.
- the preferred exfoliant for use in the present invention is lactic acid.
- An absorbent carrier may be used in conjunction with the present invention.
- a variety of materials can be employed as a carrier for delivering a dermatologically active ingredient or agent, for example, an exfoliant, such as an alpha hydroxy acid to the skin in an active agent form while protecting the active ingredient from other cosmetic ingredients that may deactivate it.
- Suitable carrier materials include but are not limited to polymeric organic microspheres and inorganic particulates.
- microspherical powders useful in the preparation of the cosmetic materials of this invention include organic polymeric materials, such as, polyethylene, polypropylene and copolymers thereof, polyurethane, polyesters, polyamides, polymethylmethacrylate, nylon, ethylene acrylates copolymers and polyvinylidene copolymers.
- organic polymeric materials such as, polyethylene, polypropylene and copolymers thereof, polyurethane, polyesters, polyamides, polymethylmethacrylate, nylon, ethylene acrylates copolymers and polyvinylidene copolymers.
- any non-toxic, non-irritating, cosmetically compatible organic polymeric material that can be provided in a satisfactorily adsorbent or absorbent form for the purposes of this invention, and which is compatible with the anhydrous vehicle, can be used.
- inorganic particulates include talc, clays, organic modified clays, kaolin, mica, calcium salicylate and various carbonates of various metals, for example, calcium and magnesium.
- the carrier particles should not be too large or their presence as a component of the composition will be apparent to the user and may give a particulate coarse or sandy, rather than, smooth feel to the cosmetic.
- at least eighty percent of the particles preferably do not exceed 50 microns and more preferably do not exceed 20 microns.
- the particles should be too small, or they may be absorbed in the sebaceous follicles, which, while acceptable, is not desired, and will provide too small a storage volume for the passenger dermatologically active agent.
- the carrier particles should be relatively large to be able to release the active ingredient from either the surface or through surface openings from interior volumes of the particles.
- At least eighty percent of the carrier particles are in excess of 10 microns in diameter.
- a particularly preferred range for at least eighty percent of the particles is from 10 to 20 microns, more preferably from 10 to 15 microns.
- a useful average particle size is from 12 to 20 microns.
- a porous carrier particle is particularly preferred wherein the liquid phase absorbed within the particle occupies, for example, from 10 to 90 percent of the particle's volume, rather than simply being retained on the particle's surface.
- An absorbent matrix powder serving as a carrier for topical delivery of the dermatologically active agent or dermatologically active solution can comprise porous synthetic organic polymeric microspheres, for example, a cosmetically acceptable polyamide such as nylon 12, in a proportion of from about 0.1 to about 40.0 percent, preferably from about 5.0 to about 20.0 percent, and more preferably from about 6.5 to about 10.0 percent by weight of the cosmetic composition.
- the organic polymeric microspheres impart desirable feel properties, for example, creamy, powdery and silky qualities to consumer formulations, and enhance the light-scattering qualities of the formulation. When discharged of AHA or other dermatologically active agents the organic polymeric microspheres are available to absorb skin oils, helping control oil breakthrough.
- suitable dermatologically active agents which can be delivered to the skin in the compositions of the invention include, but are not limited to, the following: anesthetics, for example, benzyl alcohol, lidocaine and menthol; astringents, for example, witch hazel, benzoic acid and aluminum or aluminum/zirconium salts; keratolytics, for example, resorcinol, salicylic acid, ascorbic acid and acetic acid; exfoliants, for example, lactic acid, glycolic acid and other alpha or beta hydroxy acids; vasoconstrictors, for example, phenylepinephine hydrochloride; external analgesics, for example, tripelennamine hydrochloride and camphor; anti-inflammatory agents, for example, salts of glycyrrhizic acid, alpha bisabolol; salicylate derivatives and ibuprofen; anti-irritants, for example, allantoin, proteins, trimethyl glycine,
- Moisturizers when added directly to the skin lightening composition, are most preferably added in the particle carriers to prevent oxidation of the active acidic whitening agents.
- Equivalents to the foregoing examples and other guidelines herein will suggest other dermatologically active agents suitable for including in the compositions of the invention. Some such agents are listed in OTC Monographs and the Physician's Desk Reference which are hereby included herein by reference thereto. Some of these agents, and others, are disclosed in Schaefer et al., U.S. Patent No. 5,292,512, the disclosure of which is also incorporated herein by reference thereto.
- the most preferred dermatologically active agents for use in the present invention are exfoliants, such as alpha hydroxy acids, specifically lactic acid.
- One or more dermatologically active agents are present in the cosmetic composition of the present invention in a range of from about 0.01 to about 20.0 percent by weight of the composition can be incorporated into preferred embodiments of the current composition. More preferably these agents can be added from about 0.5 to about 8.0 percent and still more preferably from about 1.0 to about 5.0 percent. Other active agents can be used in equivalent proportions depending upon their activity.
- dermatologically active agents possess properties, for example a low enough melting point, that enable them to be absorbed or adsorbed directly into or onto the carrier matrix
- others are in crystalline form at room temperature, and are preferably dissolved in a suitable hydrophilic solvent system for the active agent.
- the solvent system should have little or no affinity for the essentially anhydrous base. This is important to retaining both the solvent and its dermatologically active solute in or on the carrier and to preserving the intended functionality of the dermatologically active agent.
- the solvent should be suitably viscous to further help retard the migration of the dermatologically active agent from the carrier.
- the solvent should be inert or inactive with respect to, or at least not negatively impact the functionality of the dermatologically active agent.
- liquid hydrophilic solvents or dispersion phase media that can be used alone or in combination as adjuvants to assist the loading of the dermatologically active agent or agents onto or into the particular carrier include but are not limited to water, alcohols and ethers.
- a suitable class of alcohols comprises mono-, di-, tri- or polyhydroxy alcohols having the formula:
- R 1 H, CH 3 , O-CH 3 , O-CH 2 -CH 3
- Suitable examples of such compounds include glycerine, propylene glycol, dipropylene glycol, propanol, isopropanol, butanol, isobutanol, pentanol, isopentanol, neopentanol, diglycerol, polyglycerol, sorbitol, polyethylene glycerol, and polyol.
- Suitable ethers include unsubstituted and substituted ethers for example UCON® fluid, Union Carbide Corp. or DOWANOL® fluids, Dow Chemical Company or CARBITOL® and CELLOSOLVE® solvents from Union Carbide.
- suitable viscous, hydrophilic solvents or blends of solvents can be used with the dermatologically active agent in a proportion of from about 99:1 to about 1 :99.
- preferred proportions are chosen to exploit the physical or physico-chemical characteristics of the solvent to deliver the dermatologically active agent in an active form in a liquid phase for uptake by absorbent carrier particles.
- greater proportions of solvent are preferred.
- An example of a preferred proportions are from about 1 :1 to about 1 :20 parts agent to solvent, on a weight basis.
- a preferred solvent for a dermatologically active agent for example, an alpha hydroxy acid (AHA) is glycerine.
- AHA alpha hydroxy acid
- the solvent's viscosity helps retain the AHA within or on the particulate carrier while the hydrophilicity permits skin moisture to draw dissolved AHA out of or off of the microparticle.
- the composition also preferably includes an anti-aging agent, such as, Vitamin A palmitate or retinol derivatives, specifically, retinoic acid.
- an anti-aging agent such as, Vitamin A palmitate or retinol derivatives, specifically, retinoic acid.
- the anti-aging agent improves the elasticity of the skin and minimizes the formation of fine wrinkles.
- the anti-aging agent is present in the cosmetic composition according to the present invention in an amount of from about 0.20 to about 10.0 percent by weight, more preferably about 1.0 to about 6.0 percent by weight, and most preferably about 1.5 to about 2.5 percent by weight.
- the cosmetic base may be aqueous or anhydrous. Suitable cosmetic base materials are well understood by the skilled artisan. While an aqueous - base can be used, an anhydrous hydrophobic base is preferred. In the event an aqueous base is used, the skilled artisan should minimize, to the extent possible, contact between the water in the base and the active agents that may be degraded by oxidation.
- the preferred essentially or substantially anhydrous base can provide a medium or vehicle for dispersal of the active-agent which medium can be liquid or semi-solid, for example, a dispersant or solvent for other cosmetic ingredients bringing desired cosmetic properties to the composition.
- the anhydrous base can thus comprise a more or less volatile hydrophobic cosmetic solvent in which a gelling agent is optionally dispersed to provide a desired consistency.
- the whitening cosmetic composition of the present invention is best used in conjunction with an aqueous source, most often a moisturizing composition.
- the moisturizer is preferably applied to a surface of the skin before the whitening cosmetic composition is applied. This is not, however, necessary.
- the whitening cosmetic composition of the present invention in addition to the active ingredients can contain a variety of products or processing aids.
- the addition of such materials is readily understood by the skilled artisan and while a variety of additives are described below, the description is not intended to be limiting.
- the invention provides for a film-forming agent to assist with the adhesion of the particulate carrier onto the skin and to help form an occlusive barrier to enhance the buildup of water on or near the surface of the skin.
- film-forming is meant that an essentially continuous layer of product is formed on the surface of the skin.
- occlusive is meant that a barrier is placed on the surface of the skin which barrier substantially blocks or retards the loss of volatile materials from the skin's surface and enables them to build up in the upper layers of the skin.
- the barrier film is preferably hydrophobic.
- Suitable cosmetic film-forming agents that can be used alone or in combination include but are not limited to metallic soaps, waxes and film-forming emollients. Some non-limiting examples of each of these classes of cosmetic film-forming agents will now be described. Others will be known to those skilled in the art.
- Metallic soaps are useful materials which function to aid adhesion and to promote the formation of a hydrophobic film.
- the metallic soap gelling agent or agents can be an alkaline earth or aluminum alkanoate of from six to twenty carbon atoms, for example, the laurate, oleate, or stearate salts of calcium, magnesium, zinc, aluminum or lithium or mixtures thereof.
- a cosmetic metal soap, for example zinc laurate can be used in a proportion of from about 1.0 to about 5.0 percent, preferably about 3.0 percent by weight of the composition.
- Metallic soap functions as an ionic gelling agent, aids adhesion and adds to hydrophobic film formation.
- R-X a long chain saturated, unsaturated, cyclic or branched chain alkyl radical of from C 8 to C 1 000000
- X is -H, -OR 1 or -C-OR 11 , where R 1 is H, or a saturated, unsaturated, cyclic or branched chain alkyl radical of from C,, to C 24 ; R 1 is H or residue of a mono-, di-, tri- or polyhydroxy compound capable of forming a mono-, di-, tri or polyester.
- Preferred waxes have melting points which exceed 100°F.
- Materials such as glyceryl wax esters, beeswax, ceresin wax, carnauba wax, candelilla wax and other cosmetically acceptable waxes can be used.
- a total wax content of from 0 to 10.0 percent is adequate for formulating satisfactory cosmetics, pursuant to the invention.
- total wax content does not exceed 5.0 percent and more preferably not 3.0 percent.
- Suitable waxes are, for example, glyceryl tribehenate, ceresin wax and microcrystalline wax used in proportions of from about 0.00 to about 5.00 percent, preferably about 0.1 to 1.5 percent. More preferably, from about 0.25 to 0.5 percent of waxes such as glyceryl tribehenate and a somewhat higher proportion of about 1 to 2 percent of a ceresin was are used.
- the low wax content attainable with cosmetic compositions according to the invention has the advantage of providing low drag and enhanced removability.
- Useful wax functions are adhesion, imparting a creamy feel to the product, film forming and increasing viscosity.
- Emollients useful in the present invention include those with the following formula C n H (2n + 2.x) , where n is an integer from 6 to greater than 1 million and x is 0 or an even integer no greater than n and may include saturated, unsaturated, branched and cyclic hydrocarbon chains. Examples include: mineral oil, petrolatum, PERMETHYL® fluids, and polybutylenes.
- film-forming emollients include the mono-, di-, tri- or polybranched, -cyclic, -saturated or -unsaturated alkyl esters or ethers of di, tri or polyhydroxy compounds, for example, ethylene glycol, propylene glycol, glycerine, sorbitol or polyol.
- emollients include but are not limited to vegetable oils, for example, soybean oil, babassu oil, castor oil, cottonseed oil, Chinese tallow oil, crambe oil, perilla oil, Danish rapeseed oil, rice bran oil, palm oil, palm kernel oil, olive oil, linseed oil, coconut oil, sunflower oil, safflower oil, peanut oil, and corn oil.
- Preferred saturated and unsaturated vegetable oils are those having fatty acid components with 6 to 24 carbon atoms.
- Suitable emollient film-forming agents include esters of the formula:
- R., and R 2 are saturated, unsaturated, branched or cyclic alkyl radicals of 2 to 24 carbon atoms and n is an integer from 0 to about 20.
- the novel cosmetic compositions of the invention may also contain a silicone material to provide some measure of auxiliary film-forming ability.
- Suitable silicone materials are preferably insoluble in water and include cyclomethicone polyalkylsiloxanes, polyarylsiloxanes, polyalkylarylsiloxanes, ⁇ polysiloxane gums, amino functional polysiloxanes and polyethersiloxane copolymers. Teachings directed to additional suitable silicone materials can be found in U.S 4,788,006; U.S.4,341 ,799; 4,152,416; 3,964,500; 3,208,911 ; 4,364,837 and U.S. 4,465,619, the disclosures of all of which are hereby incorporated herein by reference thereto.
- auxiliary film-forming agents comprises substances formed by the polymerization of alkylene oxide monomers of the formula
- n is an integer from 0 to about 3.
- These materials can be either a homogeneous polymer or a copolymer of two or more monomers.
- homogeneous polymers include polypropylene oxide and polybutylene oxide. Typically, the molecular weights of these materials are between 100 and 10,000 daltons. Additionally, these materials can be condensed with a mono or polyhydroxyalkyl alcohol as exemplified by the UCON® fluids from Union Carbide Corp.
- the film-forming agent can be used alone or in combination with other film-forming agents to achieve desired aesthetic properties in the final preparation.
- a preferred range of film-forming agents is from 1 to 99%, more preferably from about 1 to 50% by weight of the composition.
- Suitable non-hardening film formers for example, dimethicone, can be used in proportions of from about 0.5 to about 5.0 percent, preferably about 0.6 to 1.5 percent, and more preferably about 1.0 percent.
- Preferred functions include film forming, skin protectant or water-barrier forming agent, lubricious and silky emollient.
- Film enhancing agents for example, aluminum-myristate-treated mica, in a proportion of from about 4.0 to about 20.0 percent by weight of the composition, preferably about 5.0 to 8.0 percent, and more preferably 6.5 percent can be used.
- Preferred film enhancer functions include adhesion to skin, imparting of a creamy and silky feel to the composition and enhancing hydrophobic film formation.
- the invention also provides a novel film-forming system which comprises relatively high proportions of a particulate mineral gelling agent, for example, a bentonite-clay based gelling agent, and of a metallic soap gelling agent, such as, for example, zinc laurate, while using only a small proportion of wax, if any.
- a particulate mineral gelling agent for example, a bentonite-clay based gelling agent
- a metallic soap gelling agent such as, for example, zinc laurate
- carrier loading of an AHA is achieved by dissolving the AHA in glycerine and absorbing the glycerine-dissolved AHA on porous microspheres or fine polymer particles.
- AHA e.g., lactic acid
- This system is intended for use in a hydrophobic environment where the AHAs remain in stored within the porous microspheres.
- microspheres When applied to the skin, as the cosmetic is rubbed or massaged into the skin, microspheres are brushed across the skin surface, bringing them into contact with moisture which releases the hydrophilic AHA- glycerine system from the microporous polymer particles. Once discharged the now-hollow microspheres are available to absorb oil, moderating oil-breakthrough tendencies.
- the AHA is preferably loaded on the carrier particles, for example, porous nylon particles in a liquid medium which should be sufficiently viscous to be held in the particles' pores during formulation.
- Lactic acid melts at 16.8°C and can be absorbed into porous carrier particles, without the need for any adjuvant, at temperatures above this melting point, by blending in appropriate proportions of microshperes to lactic acid, for example, near 1 :1 by weight, until the lactic acid is absorbed.
- Other acids such as a mixture of fruit acids, can be similarly loaded onto carrier particles by agitating i.e., blending, by using fine powders with a sufficiently small particle size to be contained in the carrier's pores.
- Skin lightening or whitening benefits resulting from the whitening cosmetic composition may begin to be apparent only after long-term use of the cosmetic composition of the invention on a regular, for example daily, basis for a period of weeks for example, four or six weeks or more.
- a preferred hydrophobic vehicle for the active-agent-loaded microsphere particles is a silicone gel, which is preferably formulated using a volatile silicone solvent such as a dimethicone.
- a preferred gelling agent is a trihydroxystearine.
- a volatile solvent for example a cyclomethicone, preferably the pentamer form, can be used as a hydrophobic vehicle, for example for a cream-to-powder composition. Suitable proportions are from about 20.0 to about 70.0 percent by weight of the composition, preferably about 30 to 40 percent, and more preferably about, 33.0 percent.
- the volatile solvents function as wetting agents while quickly evaporating upon application.
- a gelling agent suitable for a volatile solvent for example, quatemium- 18 bentonite, is present from about 1.0 to about 15.0 percent, more preferably from about 3 to 10 percent, and more preferably about 5.0 to 6.0 percent.
- the gelling agent physically stabilizes the composition and functions as a pigment- suspension vehicle, if a pigment is present, and also may absorb oil and reduce shine.
- a wetting agent may be utilized. If a wetting agent, for example, sorbitan isostearate, is used, it is present in an amount of from about 1.0 to about 10.0 percent by weight of the composition, preferably about 3.5 to 4.5 percent, and more preferably about 4.0 percent can be used. ⁇ Preferred wetting agents allow for increased capacity of solid material, and impart a hydrophobic film.
- synthetic polymeric microspheres in addition to the AHA carrier powder for example polymethylmethacrylate, can be used in a proportion of from about 8.0 to about 20.0 percent by weight of the composition, preferably about 10.0 to 15.0 percent, and more preferably 12.0 percent.
- additional polymeric microspheres act as feel enhancers, providing a "ball bearing" feel on application, and a velvety, dry feel after application and evaporation of the solvent. Additional functions include light scattering and imparting of a powdery feel to the product.
- An oily, low-volatility solvent ester for example, isononyl isononanoate, is useful for volatility and molecular weight control of the solvent system in a proportion of from about 1.0 to about 10.0 percent by weight, preferably from about 4.0 to 6.0 percent, and more preferably about 5.0 percent of a solvent.
- Preferred solvents also function as lipophilic emollients, aid in the solubilization of the ingredients and are miscible with the volatile carrier solvent (for example, dimethicone).
- One or more oil soluble moisturizers for example lauryl PCA, in a proportion of from about 0.4 to about 2.5 percent, preferably about 0.5 percent, or cetyl dimethicone, in a proportion of from about 1.0 to about 5.0 percent by weight of the composition, can be used to enhance moisturization. Cetyl dimethicone provides a light, dry feel and aids film formation.
- a moisturizer may be incorporated into the cosmetic composition of the present invention but if it is incorporated, it is preferably loaded into porous microspheres and dispersed in the composition.
- a moisturizer may be applied to the skin before application of the whitening cosmetic according to the present invention.
- the whitening cosmetic of the present invention functions best in the presence of a source of water.
- the water source is for the purpose of hydrating the skin.
- Suitable hydration sources includes liquid water added specifically to hydrate the skin or incidently, such as, directly after a bath or shower. Hydration can also be achieved through the application of a moisturizer or other aqueous phase composition.
- Kaolin or other oil absorbents can be used in a proportion of from about 0.50 to about 3.0 percent by weight of the composition, preferably about 0.7 to 1.5 percent, and more preferably 1.0 percent.
- Preferred oil absorbent functions include absorption of excess skin oils, skin adhesion, light diffusion, and opacification.
- An opacifier for example titanium dioxide, can be used in a proportion of from about 0.10 to about 5.0 percent by weight of the composition, preferably about 0.3 to 1.0 percent, and more preferably 0.50 percent to provide coverage and help mask skin defects.
- a volatile polar activator solvent for the gellant for example hexylene glycol
- hexylene glycol can be used in a proportion of from about 0.75 to about 3.0 percent by weight of the composition, preferably less than about 2.0 percent, more preferably not greater than about 1.0 percent. This will act as a binder plasticizing agent, solvent and softener while providing resistance to moisture and oxidation.
- Preservatives such as, for example, methyl or propyl paraben, can be used in proportions of, for example, 0.1 to 0.3 percent by weight, as is known to those skilled in the art.
- vitamin E linoleate in a percentage of about 0.10 percent as a supplemental moisturizer
- vitamin E acetate at about 0.10 percent which functions as a free radical scavenger and an antioxidant
- retinyl palmitate at about 0.1 percent which functions as a derivative of retinoic acid to reduce fine lines
- ceramides at a percentage below about 0.3 percent which function as a skin firmer
- sphingolipids serve the function of skin firming at a percentage below about 0.3 percent. Sphingolipids also function to improve the skin's barrier thereby increasing moisturization and decreasing penetration of irritant substances.
- a class of cyclomethicone compounds that is preferred for use in the cosmetic compositions of this invention is illustrated by compounds of the formula -[R 1 R 2 SiO] n -, in which R., and R 2 is each lower alkyl having from one to four carbon atoms with or without substitutes selected from the group consisting of halo, hydroxyl, carboxyl or methoxy and n is from 3 to 6; which compounds are cyclized.
- the volatile cyclomethicone solvent used can be a single one of the foregoing compounds or a mixture thereof and the compound or compounds can be a homopolymer in which all n monomeric units are similar, or a heteropolymer in which they are different.
- Some preferred cyclomethicones are dimethicones especially homopolymers in which n is 4 or 5; and R., and R 2 is each methyl such as octamethylcyclotetrasiloxane and decamethylcyclopentasiloxane.
- a lotion, a powder, a cream, a stick other optional ingredients can be used, as known to those skilled in the art, in proportions known to those skilled in the art.
- Such ingredients include, but are not limited to, fragrance, color, pigments, preservatives, wetting agents, oil absorbents, opacifiers, and antioxidants.
- An ascorbic acid dry mixture was produced by combining the following materials in the following proportions by weight.
- Example 2 Using the ascorbic.acid dry mixture of Example 1 , a cosmetic composition was prepared by mixing the ingredients listed below in the proportions noted. The composition was applied to skin causing improved skin tone and lightening.
- a kojic acid dry mixture was produced by combining the following materials in the following proportions by weight.
- a cosmetic composition was prepared by mixing the ingredients listed below in the proportions noted. The composition was applied to skin on the hand causing improved skin tone and lightening.
- compositions according to the present invention were tested using three panels of 20 women.
- the panelists were 35-60 and had to meet a Fitzpatrick skin classification of I to III.
- the panelists were excluded with a Modified Glogau Classification of I or IV.
- Anhydrous cosmetic composition according to the present invention along with a body care moisturizing lotion
- Visible action skin revealing lotion is a moisturizer produced as a combination of the following ingredients in the proportions noted as a percentage by weight.
- the anhydrous cosmetic composition according to the present invention is a skin whitening or lightening composition.
- the anhydrous composition includes the following ingredients as a percentage by weight: 5.0% Dimethicone 10.0% Cetyl Dimethicone 0.38% Glyceryl Tribehenate 1.72% Paraffin Wax 0.38% Microcrystalline Wax 10.4% Cyclomethicone 6.97% Cyclomethicone 1.05% Sodium lactate 6.0% Dry mix of kojic acid 10.0% Lactic acid blend 4.0% Nylon 12 11.0% PM MA Beads 31.0% Thixogel RCM 0.2% Tocopherol 0.5% Tocopherol Acetate 0.1% Retinyl Palmitate 0.5% Ethylhexyl P-Methoxycinnamate 0.3% Lavender 0.5% Hydrophobic Sphingolipids
- the compositions according to the invention resulted in a 20 to 35% improvement in evenness of skin tone, a 30 to 35% increase in skin elasticity,
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR9810062-9A BR9810062A (en) | 1997-06-20 | 1998-06-15 | Cosmetic composition containing a bleaching agent as well as use of a water source in combination with it |
SK1736-99A SK173699A3 (en) | 1997-06-20 | 1998-06-15 | Cosmetic composition containing a whitening agent and an exfoliant |
JP50465299A JP2002507202A (en) | 1997-06-20 | 1998-06-15 | Cosmetic composition containing whitening agent and descaling agent |
EA200000045A EA200000045A1 (en) | 1997-06-20 | 1998-06-15 | COSMETIC COMPOSITION CONTAINING BLEACHING AND IMPAIRING MEANS |
AU81446/98A AU8144698A (en) | 1997-06-20 | 1998-06-15 | Cosmetic composition containing a whitening agent and an exfoliant |
EP98931284A EP1006995A1 (en) | 1997-06-20 | 1998-06-15 | Cosmetic composition containing a whitening agent and an exfoliant |
KR19997012078A KR20010014048A (en) | 1997-06-20 | 1998-06-15 | Cosmetic composition containing a whitening agent and an exfoliant |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5038397P | 1997-06-20 | 1997-06-20 | |
US60/050,383 | 1997-06-20 | ||
US88588497A | 1997-06-30 | 1997-06-30 | |
US08/885,884 | 1997-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998058628A1 true WO1998058628A1 (en) | 1998-12-30 |
Family
ID=26728206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/012453 WO1998058628A1 (en) | 1997-06-20 | 1998-06-15 | Cosmetic composition containing a whitening agent and an exfoliant |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1006995A1 (en) |
JP (1) | JP2002507202A (en) |
KR (1) | KR20010014048A (en) |
CN (1) | CN1265025A (en) |
AU (1) | AU8144698A (en) |
BR (1) | BR9810062A (en) |
EA (1) | EA200000045A1 (en) |
SK (1) | SK173699A3 (en) |
WO (1) | WO1998058628A1 (en) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1002526A1 (en) * | 1998-11-18 | 2000-05-24 | Amway Corporation | Skin whitening composition containing bearberry extract and a reducing agent |
FR2787711A1 (en) * | 1998-12-29 | 2000-06-30 | C3D Sarl | COSMETIC COMPOSITION WITH DEPIGMENTING ACTIVITY AND ITS USE |
WO2001013955A1 (en) * | 1999-08-19 | 2001-03-01 | Lavipharm S.A. | Film forming polymers, methods of use, and devices and applications thereof |
FR2804863A1 (en) * | 2000-02-10 | 2001-08-17 | C3D | Compositions for the depigmentation of skin contain a tyrosinase inhibitor and a hydrogen peroxide releasing agent in two distinct formulations stored as parallel or concentric layers which only mix upon release |
WO2001070189A1 (en) * | 2000-03-21 | 2001-09-27 | Unilever Plc | Method and composition for skin lightening applying carboxylic acids |
US6379456B1 (en) * | 1999-01-12 | 2002-04-30 | Halliburton Energy Services, Inc. | Flow properties of dry cementitious and non-cementitious materials |
US6478869B2 (en) * | 1999-01-12 | 2002-11-12 | Halliburton Energy Services, Inc. | Flow properties of dry cementitious materials |
WO2002067886A3 (en) * | 2001-02-28 | 2003-03-20 | Colgate Palmolive Co | Skin composition |
EP1358871A1 (en) * | 2001-01-16 | 2003-11-05 | TSUMURA & CO. | Bath additive composition |
WO2003092636A1 (en) * | 2002-05-06 | 2003-11-13 | Unilever Plc | Personal care composition with color change indicator |
US6660080B2 (en) | 1999-01-12 | 2003-12-09 | Halliburton Energy Services, Inc. | Particulate flow enhancing additives |
WO2006001567A1 (en) * | 2004-06-24 | 2006-01-05 | Bioleaders Corporation | Poly-gamma-glutamic acid-vitamin complex and use thereof |
EP1640042A1 (en) | 2004-08-27 | 2006-03-29 | Lancaster Group GmbH | Cosmetic skin-whitening and cleansing composition comprising extracts from lotus, kiwi, orchids and liquorice |
US7083781B2 (en) | 1999-08-19 | 2006-08-01 | Lavipharm S.A. | Film forming polymers, methods of use, and devices and applications thereof |
WO2007020536A2 (en) * | 2005-07-12 | 2007-02-22 | L'oréal | Cosmetic method for the targeting of wrinkles |
FR2892019A1 (en) * | 2005-10-14 | 2007-04-20 | Oreal | Caring for wrinkled skin comprises applying composition including pulverulent phase comprising porous particles which comprise antiwrinkle active principle; and applying composition including fatty and/or aqueous phase comprising solvent |
US7449613B2 (en) | 2001-07-03 | 2008-11-11 | The Procter & Gamble Company | Film-forming compositions for protecting skin from body fluids and articles made therefrom |
WO2009031788A1 (en) * | 2007-09-04 | 2009-03-12 | Cotde, Ltd. | Cosmetic composition comprising vitamin c |
FR2931661A1 (en) * | 2008-05-30 | 2009-12-04 | Galderma Res & Dev | NOVEL DEPIGMENTING COMPOSITIONS IN THE FORM OF AN ANHYDROUS VASELIN - FREE AND ELASTOMER - FREE COMPOSITION COMPRISING A SOLUBILIZED PHENOLIC DERIVATIVE AND A RETINOID. |
WO2009156679A1 (en) * | 2008-05-30 | 2009-12-30 | Galderma Research & Development | Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
DE102012211030A1 (en) | 2012-06-27 | 2014-01-02 | Beiersdorf Ag | Use of creatine for lightening cosmetic preparation comprising active ingredients with natural color |
FR3019040A1 (en) * | 2014-03-31 | 2015-10-02 | Arkema France | COSMETIC COMPOSITION FOR SKIN LIGHTENING |
CN110772442A (en) * | 2018-07-31 | 2020-02-11 | 株式会社Lg生活健康 | Cosmetic composition comprising eutectic mixture |
EP3815670A4 (en) * | 2018-06-26 | 2022-04-20 | Natura Cosméticos S.A. | Stable skin-lightening cosmetic composition |
WO2022165696A1 (en) * | 2021-02-04 | 2022-08-11 | L'oreal | Composition for improving the appearance of keratin materials |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100821482B1 (en) * | 2002-02-05 | 2008-05-21 | (주)아모레퍼시픽 | External skin application composition for skin whitening |
KR20030067051A (en) * | 2002-02-06 | 2003-08-14 | 주식회사 코리아나화장품 | Cosmetic Compositions Comprising Lactate and Kojic Acid for Skin Whitening |
DE10215342A1 (en) * | 2002-03-28 | 2003-10-23 | Coty Bv | Skin lightening cosmetic |
KR100515764B1 (en) * | 2002-10-19 | 2005-09-21 | 김기철 | Face cleansing agent |
FR2856594B1 (en) * | 2003-06-26 | 2006-03-03 | Oreal | POROUS PARTICLES CHARGED WITH ACTIVE (S) COSMETIC OR PHARMACEUTICAL COMPOUND (S) |
US7429391B2 (en) * | 2004-01-30 | 2008-09-30 | Access Business Group International Llc | Holistic composition and method for reducing skin pigmentation |
FR2894961B1 (en) * | 2005-12-16 | 2008-05-16 | Oreal | USE OF CERAMIDES FOR DEPIGMENTING THE SKIN |
FR2895678B1 (en) * | 2006-01-05 | 2008-08-15 | Oreal | COSMETIC USE OF A MINT EXTRACT |
CN102335287A (en) * | 2010-07-18 | 2012-02-01 | 孔垂冯 | Mixture capable of removing acnes and acne scars |
CN102727415B (en) * | 2012-06-18 | 2013-07-24 | 曾技 | Anti-allergic cosmetic and production process thereof |
EP2789369B1 (en) * | 2013-04-14 | 2018-06-06 | Symrise AG | A composition for lightening skin and hair |
FR3022775B1 (en) * | 2014-06-30 | 2018-03-02 | L'oreal | ANHYDROUS COMPOSITION COMPRISING A LIPOPHILIC GELIFIER, AT LEAST TWO SEPARATE LOADS OF ANOTHER AND A FATTY PHASE |
KR102114993B1 (en) * | 2015-10-15 | 2020-05-25 | 주식회사 파이안에스테틱스 | Cosmetic composition comprising water soluble scrub particle containing polypeptide and/or cell culture conditioned media |
US11045398B2 (en) * | 2017-12-27 | 2021-06-29 | L'oreal | Skin-brightening compositions and methods |
CN108096111A (en) * | 2018-01-10 | 2018-06-01 | 广州市聚吉科绿色化学共性技术研究院有限公司 | A kind of improvement chicken dermal compositions |
KR20220119241A (en) | 2021-02-19 | 2022-08-29 | (주)아모레퍼시픽 | Oil-dispersed composition and Cosmetics for lip care using the same |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2259014A (en) * | 1991-08-23 | 1993-03-03 | Fischer Pharma Ltd | Compositions containing flavonoids |
WO1994009756A1 (en) * | 1992-11-05 | 1994-05-11 | Unilever Plc | Retinol containing cosmetic composition |
FR2723316A1 (en) * | 1994-08-04 | 1996-02-09 | Thorel Jean Noel | Compsn. for skin de-pigmentation caused by hyper:activation melanocytes |
WO1996021422A1 (en) * | 1995-01-11 | 1996-07-18 | Mary Kay Inc. | Anhydrous cosmetic compositions with dermatologically active agents |
FR2736263A1 (en) * | 1995-07-07 | 1997-01-10 | C3D Sarl | DEPIGMENTING DERMOCOSMETIC COMPOSITION AND USE THEREOF |
-
1998
- 1998-06-15 SK SK1736-99A patent/SK173699A3/en unknown
- 1998-06-15 WO PCT/US1998/012453 patent/WO1998058628A1/en not_active Application Discontinuation
- 1998-06-15 JP JP50465299A patent/JP2002507202A/en active Pending
- 1998-06-15 CN CN98807488A patent/CN1265025A/en active Pending
- 1998-06-15 KR KR19997012078A patent/KR20010014048A/en not_active Application Discontinuation
- 1998-06-15 EA EA200000045A patent/EA200000045A1/en unknown
- 1998-06-15 BR BR9810062-9A patent/BR9810062A/en unknown
- 1998-06-15 AU AU81446/98A patent/AU8144698A/en not_active Abandoned
- 1998-06-15 EP EP98931284A patent/EP1006995A1/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2259014A (en) * | 1991-08-23 | 1993-03-03 | Fischer Pharma Ltd | Compositions containing flavonoids |
WO1994009756A1 (en) * | 1992-11-05 | 1994-05-11 | Unilever Plc | Retinol containing cosmetic composition |
FR2723316A1 (en) * | 1994-08-04 | 1996-02-09 | Thorel Jean Noel | Compsn. for skin de-pigmentation caused by hyper:activation melanocytes |
WO1996021422A1 (en) * | 1995-01-11 | 1996-07-18 | Mary Kay Inc. | Anhydrous cosmetic compositions with dermatologically active agents |
FR2736263A1 (en) * | 1995-07-07 | 1997-01-10 | C3D Sarl | DEPIGMENTING DERMOCOSMETIC COMPOSITION AND USE THEREOF |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1002526A1 (en) * | 1998-11-18 | 2000-05-24 | Amway Corporation | Skin whitening composition containing bearberry extract and a reducing agent |
FR2787711A1 (en) * | 1998-12-29 | 2000-06-30 | C3D Sarl | COSMETIC COMPOSITION WITH DEPIGMENTING ACTIVITY AND ITS USE |
WO2000038648A1 (en) * | 1998-12-29 | 2000-07-06 | C3D S.A.R.L. | Cosmetic composition with depigmenting activity and use thereof |
US6610139B2 (en) | 1999-01-12 | 2003-08-26 | Halliburton Energy Services, Inc. | Methods of preparing particulate flow enhancing additives |
US6379456B1 (en) * | 1999-01-12 | 2002-04-30 | Halliburton Energy Services, Inc. | Flow properties of dry cementitious and non-cementitious materials |
US6478869B2 (en) * | 1999-01-12 | 2002-11-12 | Halliburton Energy Services, Inc. | Flow properties of dry cementitious materials |
US6660080B2 (en) | 1999-01-12 | 2003-12-09 | Halliburton Energy Services, Inc. | Particulate flow enhancing additives |
WO2001013955A1 (en) * | 1999-08-19 | 2001-03-01 | Lavipharm S.A. | Film forming polymers, methods of use, and devices and applications thereof |
US7083781B2 (en) | 1999-08-19 | 2006-08-01 | Lavipharm S.A. | Film forming polymers, methods of use, and devices and applications thereof |
FR2804863A1 (en) * | 2000-02-10 | 2001-08-17 | C3D | Compositions for the depigmentation of skin contain a tyrosinase inhibitor and a hydrogen peroxide releasing agent in two distinct formulations stored as parallel or concentric layers which only mix upon release |
WO2001070189A1 (en) * | 2000-03-21 | 2001-09-27 | Unilever Plc | Method and composition for skin lightening applying carboxylic acids |
EP1358871A1 (en) * | 2001-01-16 | 2003-11-05 | TSUMURA & CO. | Bath additive composition |
EP1358871A4 (en) * | 2001-01-16 | 2004-09-08 | Tsumura & Co | Bath additive composition |
WO2002067886A3 (en) * | 2001-02-28 | 2003-03-20 | Colgate Palmolive Co | Skin composition |
US7449613B2 (en) | 2001-07-03 | 2008-11-11 | The Procter & Gamble Company | Film-forming compositions for protecting skin from body fluids and articles made therefrom |
WO2003092636A1 (en) * | 2002-05-06 | 2003-11-13 | Unilever Plc | Personal care composition with color change indicator |
US6733766B2 (en) | 2002-05-06 | 2004-05-11 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal care composition with color change indicator |
AU2003224092B2 (en) * | 2002-05-06 | 2006-09-14 | Unilever Plc | Personal care composition with color change indicator |
WO2006001567A1 (en) * | 2004-06-24 | 2006-01-05 | Bioleaders Corporation | Poly-gamma-glutamic acid-vitamin complex and use thereof |
EP1640042A1 (en) | 2004-08-27 | 2006-03-29 | Lancaster Group GmbH | Cosmetic skin-whitening and cleansing composition comprising extracts from lotus, kiwi, orchids and liquorice |
WO2007020536A3 (en) * | 2005-07-12 | 2007-07-19 | Oreal | Cosmetic method for the targeting of wrinkles |
WO2007020536A2 (en) * | 2005-07-12 | 2007-02-22 | L'oréal | Cosmetic method for the targeting of wrinkles |
FR2892019A1 (en) * | 2005-10-14 | 2007-04-20 | Oreal | Caring for wrinkled skin comprises applying composition including pulverulent phase comprising porous particles which comprise antiwrinkle active principle; and applying composition including fatty and/or aqueous phase comprising solvent |
WO2009031788A1 (en) * | 2007-09-04 | 2009-03-12 | Cotde, Ltd. | Cosmetic composition comprising vitamin c |
WO2009156675A3 (en) * | 2008-05-30 | 2010-04-08 | Galderma Research & Development | Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid |
WO2009156679A1 (en) * | 2008-05-30 | 2009-12-30 | Galderma Research & Development | Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid |
FR2931661A1 (en) * | 2008-05-30 | 2009-12-04 | Galderma Res & Dev | NOVEL DEPIGMENTING COMPOSITIONS IN THE FORM OF AN ANHYDROUS VASELIN - FREE AND ELASTOMER - FREE COMPOSITION COMPRISING A SOLUBILIZED PHENOLIC DERIVATIVE AND A RETINOID. |
DE102012211030A1 (en) | 2012-06-27 | 2014-01-02 | Beiersdorf Ag | Use of creatine for lightening cosmetic preparation comprising active ingredients with natural color |
FR3019040A1 (en) * | 2014-03-31 | 2015-10-02 | Arkema France | COSMETIC COMPOSITION FOR SKIN LIGHTENING |
WO2015150694A1 (en) | 2014-03-31 | 2015-10-08 | Arkema France | Cosmetic composition for lightening the skin |
EP3815670A4 (en) * | 2018-06-26 | 2022-04-20 | Natura Cosméticos S.A. | Stable skin-lightening cosmetic composition |
CN110772442A (en) * | 2018-07-31 | 2020-02-11 | 株式会社Lg生活健康 | Cosmetic composition comprising eutectic mixture |
CN110772442B (en) * | 2018-07-31 | 2024-03-12 | 株式会社Lg生活健康 | Cosmetic composition comprising eutectic mixture |
WO2022165696A1 (en) * | 2021-02-04 | 2022-08-11 | L'oreal | Composition for improving the appearance of keratin materials |
Also Published As
Publication number | Publication date |
---|---|
SK173699A3 (en) | 2000-07-11 |
BR9810062A (en) | 2002-01-02 |
JP2002507202A (en) | 2002-03-05 |
EP1006995A1 (en) | 2000-06-14 |
CN1265025A (en) | 2000-08-30 |
KR20010014048A (en) | 2001-02-26 |
AU8144698A (en) | 1999-01-04 |
EA200000045A1 (en) | 2000-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998058628A1 (en) | Cosmetic composition containing a whitening agent and an exfoliant | |
KR101247693B1 (en) | Sebum absorption compositions | |
EP0802785A1 (en) | Anhydrous cosmetic compositions with dermatologically active agents | |
US6228385B1 (en) | Liquid antimicrobial, skin moisturizing formulation | |
RU2313328C2 (en) | Cosmetic composition containing finely dispersed and porous powder | |
EP0918505A1 (en) | Skin toning formulation | |
CA2646161A1 (en) | Cosmetic and therapeutic stick products comprising microparticles | |
JP2002538091A (en) | Skin care composition | |
JP5093998B2 (en) | Pigmentation preventing or improving agent | |
US20090285866A1 (en) | Self-healing polymer compositions | |
CA2750146C (en) | Matte skin finish compositions | |
PL189774B1 (en) | Cosmetic composition containing antiperspirant or deodorising agent and moistening cream | |
JP2000319486A (en) | Cosmetic composition containing particles of melamine- formaldehyde resin or urea-formaldehyde resin | |
JP5514268B2 (en) | Pigmentation preventing or improving agent | |
EP3897529A1 (en) | Matt-effect cosmetic composition | |
JPH11130652A (en) | Skin cosmetic | |
CA2381560A1 (en) | Skin-balance moisturizing cream | |
CA2323690C (en) | Liquid antimicrobial, skin moisturizing formulation | |
JP3657752B2 (en) | Topical skin preparation | |
MXPA99012039A (en) | Cosmetic composition containing a whitening agent and an exfoliant | |
CZ462799A3 (en) | Cosmetic preparation containing bleaching agent and peeling-causing agent | |
MXPA97005234A (en) | Cosmetic compositions anhydration with agents dermatologically acti | |
WO2008154107A1 (en) | Self-healing polymer compositions | |
JP2004277366A (en) | Solid powder cosmetic | |
CA2247907C (en) | Skin toning formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 98807488.5 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/012039 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019997012078 Country of ref document: KR Ref document number: 173699 Country of ref document: SK Ref document number: PV1999-4627 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998931284 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200000045 Country of ref document: EA |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1998931284 Country of ref document: EP Ref document number: PV1999-4627 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998931284 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997012078 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1999-4627 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019997012078 Country of ref document: KR |